The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa…
Ler MaisManagement options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with…
Ler MaisObese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials
Obese patients with atrial fibrillation are more efficiently protected from…
Ler MaisPlatelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic…
Ler MaisDOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study
DOACs for Older adults with Atrial Fibrillation and Falls: Results…
Ler MaisModern imaging of acute pulmonary embolism
Modern imaging of acute pulmonary embolism C.M.M. de Jong a); L.J.M….
Ler MaisD-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results
D-dimer and risk of venous thromboembolism recurrence: Comparison of two…
Ler MaisCharacterization of a canine freeze-dried platelet-derived hemostatic agent: A preclinical model for surgical and traumatic hemorrhage
Characterization of a canine freeze-dried platelet-derived hemostatic agent: A preclinical…
Ler MaisPlatelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease and cancer
Platelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease…
Ler Mais